Empagliflozin (BI-10773;BI 10773;BI10773) supplier|cas 864070-44-0|DC Chemicals|Supplier|Price|Buy

DC Chemicals Supply: Empagliflozin  (BI-10773;BI 10773;BI10773) supplier,cas 864070-44-0, Cat No. DC5018, In stock

Contact: website: www.dcchemicals.com,

sales@dcchemicals.com,order@dcchemicals.com,info@dcchemicals.com,
Tel: +86-21-61454686;Fax:+86-21-61642792；

Product name: Empagliflozin  (BI-10773;BI 10773;BI10773), Synonym:　BI-10773;BI 10773;BI10773, Cat No. DC5018, Cas: 864070-44-0, Chemical Name:N/A, Molecular Formula: C23H27ClO7, MW: 450.91

Empagliflozin  (BI-10773;BI 10773;BI10773),cas 864070-44-0, Purity: >98%. Best Price and quality in the market,DC Chemicals,Primary Manufacturer, confirmed by HNMR and HPLC. Empagliflozin is a potent, selective sodium glucose co-transporter-2 inhibitor that is in development for the treatment of type 2 diabetes. Empagliflozin is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2), which is found almost exclusively in the proximal tubules of nephronic components in the kidneys. SGLT-2 accounts for about 90 percent of glucose reabsorption into the blood. Blocking SGLT-2 causes blood glucose to be eliminated through the urine via the urethra. The Empagliflozin phase III clinical trial program will include about 14,500 patients. The program consists of twelve ongoing international phase III clinical trials, including a large cardiovascular outcomes trial.